Latest Breaking News On - Steve killmeyer - Page 1 : vimarsana.com

The company is working towards FDA approval of its epinephrine nasal spray, named UTULY, for treating anaphylaxis. If successful, it may replace the current anaphylaxis treatment standard, which is the needle-based EPIPEN.

Jim bornemanLisa luciferoSteve killmeyerSandy loreauxSteven hartmanNurry hongBusiness developmentBryn pharmaChief strategyBusiness development officerChief financial officerBryn pharma board